
Company valuation, historical trends, and peer comparisons.
According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.53M. This represents a change of -81.15% compared to the average of 8.13M of the last 4 quarters.
The mean historical Enterprise Value of Propanc Biopharma, Inc. over the last ten years is 171.61B. The current 1.53M Enterprise Value has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), PPCB's Enterprise Value was at its highest in in the December 2016 quarter at 42918302555.14T. The Enterprise Value was at its lowest in in the March 2023 quarter at 724.14K.
Average
171.61B
Median
4.53M
Minimum
770.61K
Maximum
1.66T
Discovering the peaks and valleys of Propanc Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 215.20%
Maximum Annual Enterprise Value = 1.66T
Minimum Annual Increase = -100.00%
Minimum Annual Enterprise Value = 770.61K
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 901.87K | -95.04% |
| 2025 | 18.18M | -100.00% |
| 2024 | 1.66T | 215.20% |
| 2023 | 770.61K | -40.21% |
| 2022 | 1.29M | 54.43% |
| 2021 | 834.61K | -100.00% |
| 2020 | 57.64B | 1.67% |
| 2019 | 3.44M | -38.63% |
| 2018 | 5.61M | -16.59% |
| 2017 | 6.73M | -33.20% |
The current Enterprise Value of Propanc Biopharma, Inc. (PPCB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
552.80B
5-year avg
331.68B
10-year avg
171.61B
Propanc Biopharma, Inc.’s Enterprise Value is less than Quest PharmaTech Inc. (8.01M), less than Gemina Laboratories Ltd. (4.83M), less than Telescope Innovations Corp. (28.04M), less than PreveCeutical Medical Inc. (17.57M), greater than Synairgen plc (1.06M), less than EOM Pharmaceuticals Holdings, Inc. (10.91M), less than Cell Source, Inc. (48.48M), less than Zenith Capital Corp. (4.83M), greater than HOOKIPA Pharma Inc. (-22891217.00), less than Sirona Biochem Corp. (3.90M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 8.01M | $5.07M | |
| 4.83M | $3.83M | |
| 28.04M | $18.46M | |
| 17.57M | $8.87M | |
| 1.06M | $110.27K | |
| 10.91M | $9.18M | |
| 48.48M | $35.96M | |
| 4.83M | $4.83M | |
| -22891217.00 | $14.40M | |
| 3.90M | $1.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Propanc Biopharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Propanc Biopharma, Inc. (PPCB)?
What is the 3-year average Enterprise Value for Propanc Biopharma, Inc. (PPCB)?
What is the 5-year average Enterprise Value for Propanc Biopharma, Inc. (PPCB)?
How does the current Enterprise Value for Propanc Biopharma, Inc. (PPCB) compare to its historical average?